Back

Symptom and functional effects of GLP-1 receptor agonists in obesity-related heart failure with preserved ejection fraction: a systematic review of randomized trials

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Nutrition, obesity, and metabolism in heart failure Pharmacotherapy Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Rubiya Ali

Memorial Healthcare System, Pembroke Pines (United States of America)

5 More presentations in this session

Presentation thumbnail
Impact of a structured outpatient nutritional intervention on nutritional status and quality of life in elderly patients with chronic heart failure: results from the BOCADOS-IC Trial
Doctor A. Esteban Fernandez (Leganes, ES)
Abstract Slides Video
Presentation thumbnail
Comprehensive evaluation of anthropometric parameters, physical and functional performance, and dietary patterns in patients with chronic heart failure: The DIET PILLARS cohort study
Doctor M. Vitolo (Modena, IT)
Abstract Slides Video
Presentation thumbnail
Tirzepatide and the prevention of heart failure in patients with obesity and atrial fibrillation: a multicenter real-world cohort study
Doctor C. Yang (Tainan, TW)
Abstract Slides Video
Presentation thumbnail
The so-called obesity paradox: real-world evidence from a national referral centre in Latin America
Doctor C. Martinez Medrano (Mexico City, MX)
Abstract Slides Video
Presentation thumbnail
The malnourished heart failure patient: the impact by ejection fraction
Doctor N. Melarkey (Newry, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Nutrition, obesity, and metabolism in heart failure

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Presentation
Impact of GLP-1 agonists on heart failure with preserved ejection fraction in obese patients: a meta-analysis of cardiometabolic and functional outcomes
thumbnail
Congress Presentation
Novel medical approach to treating obesity
thumbnail
Congress Presentation
GLP-1 receptor agonists for obesity-related heart failure with preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources